Canada · Delayed Price · Currency is CAD COSCIENS Biopharma Statistics
Total Valuation
TSX:CSCI has a market cap or net worth of CAD 8.57 million. The enterprise value is 4.40 million.
| Market Cap | 8.57M |
| Enterprise Value | 4.40M |
Important Dates
The next estimated earnings date is Wednesday, August 12, 2026.
| Earnings Date | Aug 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TSX:CSCI has 3.18 million shares outstanding. The number of shares has increased by 8.91% in one year.
| Current Share Class | 3.18M |
| Shares Outstanding | 3.18M |
| Shares Change (YoY) | +8.91% |
| Shares Change (QoQ) | -1.32% |
| Owned by Insiders (%) | 0.55% |
| Owned by Institutions (%) | n/a |
| Float | 3.17M |
Valuation Ratios
The trailing PE ratio is 1.51.
| PE Ratio | 1.51 |
| Forward PE | n/a |
| PS Ratio | 0.77 |
| PB Ratio | 0.40 |
| P/TBV Ratio | 0.40 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 0.78 |
| EV / Sales | 0.39 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -0.36 |
Financial Position
The company has a current ratio of 5.57, with a Debt / Equity ratio of 0.13.
| Current Ratio | 5.57 |
| Quick Ratio | 4.15 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.23 |
| Interest Coverage | -58.70 |
Financial Efficiency
Return on equity (ROE) is -61.79% and return on invested capital (ROIC) is -154.47%.
| Return on Equity (ROE) | -61.79% |
| Return on Assets (ROA) | -21.29% |
| Return on Invested Capital (ROIC) | -154.47% |
| Return on Capital Employed (ROCE) | -49.62% |
| Weighted Average Cost of Capital (WACC) | 12.36% |
| Revenue Per Employee | 398,767 |
| Profits Per Employee | 202,101 |
| Employee Count | 28 |
| Asset Turnover | 0.32 |
| Inventory Turnover | 2.82 |
Taxes
In the past 12 months, TSX:CSCI has paid 13,959 in taxes.
| Income Tax | 13,959 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -44.54% in the last 52 weeks. The beta is 1.88, so TSX:CSCI's price volatility has been higher than the market average.
| Beta (5Y) | 1.88 |
| 52-Week Price Change | -44.54% |
| 50-Day Moving Average | 2.38 |
| 200-Day Moving Average | 3.07 |
| Relative Strength Index (RSI) | 53.91 |
| Average Volume (20 Days) | 1,960 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TSX:CSCI had revenue of CAD 11.17 million and earned 5.66 million in profits. Earnings per share was 1.79.
| Revenue | 11.17M |
| Gross Profit | 4.18M |
| Operating Income | -11.88M |
| Pretax Income | -10.97M |
| Net Income | 5.66M |
| EBITDA | -10.57M |
| EBIT | -11.88M |
| Earnings Per Share (EPS) | 1.79 |
Balance Sheet
The company has 6.99 million in cash and 2.82 million in debt, with a net cash position of 4.16 million or 1.31 per share.
| Cash & Cash Equivalents | 6.99M |
| Total Debt | 2.82M |
| Net Cash | 4.16M |
| Net Cash Per Share | 1.31 |
| Equity (Book Value) | 21.38M |
| Book Value Per Share | 6.72 |
| Working Capital | 10.76M |
Cash Flow
In the last 12 months, operating cash flow was -12.24 million and capital expenditures -129,815, giving a free cash flow of -12.37 million.
| Operating Cash Flow | -12.24M |
| Capital Expenditures | -129,815 |
| Depreciation & Amortization | 1.30M |
| Net Borrowing | -340,946 |
| Free Cash Flow | -12.37M |
| FCF Per Share | -3.89 |
Margins
Gross margin is 37.44%, with operating and profit margins of -106.41% and 50.68%.
| Gross Margin | 37.44% |
| Operating Margin | -106.41% |
| Pretax Margin | -98.22% |
| Profit Margin | 50.68% |
| EBITDA Margin | -94.64% |
| EBIT Margin | -106.41% |
| FCF Margin | n/a |
Dividends & Yields
TSX:CSCI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.91% |
| Shareholder Yield | -8.91% |
| Earnings Yield | 66.07% |
| FCF Yield | -144.44% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 3, 2024. It was a reverse split with a ratio of 0.25.
| Last Split Date | May 3, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.25 |
Scores
TSX:CSCI has an Altman Z-Score of 0.12 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.12 |
| Piotroski F-Score | 3 |